Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Ten-percent owner · KLRA

As of 2026-09-16, Jiangsu Hengrui Pharmaceuticals Co., Ltd. has 11 Form 4 transactions on record across 1 company — 11 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $25.8MIndirect: $0$25.8Mas of 2026-09-16
  • Direct $25.8M
  • Indirect $0
KLRAdirect2,034,133 sh$25.8M

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

KLRA · 6 trades
2026-04-20: Conversion, 708,814 sh ($0)2026-04-20: Conversion, 4,968,789 sh ($0)2026-04-20: Conversion, 2,034,133 sh2026-04-20: Conversion, 2,034,133 sh2026-04-20: Conversion, 9,477,719 sh2026-04-20: Conversion, 9,477,719 sh

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
11 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-08-07—Conversion32,500,0000Form 4
2026-08-07—Conversion7,420,0917,420,091Form 4
2026-08-07—Conversion7,420,0917,420,091Form 4
2026-08-07—Conversion7,420,0917,420,091Form 4
2026-08-07—Conversion7,420,0917,420,091Form 4
2026-04-20KLRAConversion708,8140Form 4
2026-04-20KLRAConversion4,968,7890Form 4
2026-04-20KLRAConversion2,034,1332,034,133Form 4
2026-04-20KLRAConversion2,034,1332,034,133Form 4
2026-04-20KLRAConversion9,477,7199,477,719Form 4
2026-04-20KLRAConversion9,477,7199,477,719Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.